Phase I studies with pyrazole.
D000970:Antineoplastic Agents / Q000633:toxicity*; D001393:Azoles / Q000633:toxicity*; D011720:Pyrazoles
D000970:Antineoplastic Agents; D001393:Azoles; D011720:Pyrazoles; C031280:pyrazole
ANTINEOPLASTIC AGENTS/toxicology; AZOLES/toxicology